Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

Presentation TCT 2024

TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study

Presenter: Neethi Dasu

October 30, 2024

News Conference News TCT 2024

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

Yael L. Maxwell

October 29, 2024

Presentation TCT 2024

TCT 235: Efficacy and Safety of Bivalirudin and Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients Who Underwent Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis

Presenter: Hamza Naveed

October 28, 2024

Presentation TCT 2024

Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial

Presenter: Jing Chen

October 28, 2024

Presentation TCT 2024

Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial

Presenter: Jing Chen

October 28, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

Presentation TCT 2023

TCT 215: Safety of Bivalirudin Versus Heparin in Patients With ST-elevation Myocardial Infarction: a Systematic Review and Meta-analysis:

Presenter: Mostafa Elbanna

October 26, 2023

Presentation TCT 2023

TCT 538: Comparison of Limb Outcome between Hemodialysis and Non-hemodialysis Patients following Heparin-bonded Stent Graft Implantation for Femoropopliteal Lesion from LANDMARK registry

Presenter: Kazuki Tobita

October 25, 2023

Presentation TCT 2023

TCT 42: Does Heparin-induced thrombocytopenia affect in-hospital outcomes in patients presenting with ST-segment elevation myocardial infarction? A nationwide data analysis.

Presenter: Purveshkumar Patel

October 25, 2023

$Unfractionated Heparin Still Works for Primary PCI!$

Presentation TCT 2023

Unfractionated Heparin Still Works for Primary PCI!

Presenter: Rod Stables

October 25, 2023

News Conference News TCT 2022

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

Todd Neale

September 21, 2022

Presentation TCT 2022

TCT 590: Comparison of Different Doses of Heparin on Prevention of Radial Artery Occlusion After Diagnostic Transradial Catheterization

Presenter: Jose Costa Jr

September 19, 2022

News Conference News TCT 2020

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

L.A. McKeown

October 26, 2020

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Shelley Wood

October 14, 2020

Presentation TCT 2020

Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin Versus Heparin in Acute Myocardial Infarction

Presenter: Gregg Stone

October 14, 2020

News Conference News TCT 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

L.A. McKeown

October 14, 2020

Presentation TCT 2020

TCT 521: Biventricular Impella Support in a Patient With Cardiogenic Shock and Heparin-Induced Thrombocytopenia and Thrombosis

Presenter: Joshua Aymond

October 14, 2020

Presentation TCT 2017

VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI

Presenter: Thomas F. Luscher, David Erlinge

October 31, 2017

Presentation TCT 2017

VALIDATE-SWEDEHEART STEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With STEMI

Presenter: Y. S. Chandrashekhar, David J. Moliterno, Stefan K. James

October 31, 2017

Presentation TCT 2017

Why I Prefer a Heparin Plus a GPI for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, Eric R. Bates

October 30, 2017

Advertisement

TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

TCT 235: Efficacy and Safety of Bivalirudin and Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients Who Underwent Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis

Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial

Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial

What’s Going to Be Big at TCT 2024?

TCT 215: Safety of Bivalirudin Versus Heparin in Patients With ST-elevation Myocardial Infarction: a Systematic Review and Meta-analysis:

TCT 538: Comparison of Limb Outcome between Hemodialysis and Non-hemodialysis Patients following Heparin-bonded Stent Graft Implantation for Femoropopliteal Lesion from LANDMARK registry

TCT 42: Does Heparin-induced thrombocytopenia affect in-hospital outcomes in patients presenting with ST-segment elevation myocardial infarction? A nationwide data analysis.

Unfractionated Heparin Still Works for Primary PCI!

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

TCT 590: Comparison of Different Doses of Heparin on Prevention of Radial Artery Occlusion After Diagnostic Transradial Catheterization

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin Versus Heparin in Acute Myocardial Infarction

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

TCT 521: Biventricular Impella Support in a Patient With Cardiogenic Shock and Heparin-Induced Thrombocytopenia and Thrombosis

VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI

VALIDATE-SWEDEHEART STEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With STEMI

Why I Prefer a Heparin Plus a GPI for Primary PCI in STEMI!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content